Subscribe To
Multiple promising treatments accentuate the bull case for sunshine biopharma
SBFM stock is trading at a surprisingly low price, considering Sunshine Biopharma's demonstrably positive clinical results. The post Multiple Promisin...
April 26, 2022, 8:13 am
Nkarta scores huge gain on cancer treatment results
Bargain hunters may want to feast their eyes on a South San Francisco-based biotech focusing on cancer treatme...
April 25, 2022, 5:04 pm
Nkarta stock skyrockets on heavy volume after upbeat results from cancer-treatment trial
Shares of Nkarta Inc. NKTX, +95.82% skyrocketed 92.8% in very active morning trading, enough to make the stock the biggest gainer and most active list...
April 25, 2022, 10:49 am
Seastar medical is getting nasdaq listing via a merger with lmao
SeaStar Medical Inc, a medical tech corporation focusing on the development of extracorporeal therapy treatme...
April 23, 2022, 7:14 am
Pfizer: what comes after the covid-19 fire?
Pfizer now has a $31 billion warchest that incoming CFO David Denton must spend on treatments that can ...
April 21, 2022, 8:00 pm
Edesa biotech: leader in developing treatments for covid-19 and acd
Edesa is one of 4 pharmaceutical companies that received a grant from the Canadian government to develop a drug to treat COVID-19. EB01 achieved all e...
April 18, 2022, 1:53 pm
Revive therapeutics updates further on its phase 3 bucillamine in coronavirus trial
Revive Therapeutics Ltd (CSE:RVV, OTCQB:RVVTF) has updated on its Phase 3 clinical trial for Bucillamine in coronavirus (COVID-19), saying it is still...
April 12, 2022, 8:01 am
Mrna cancer treatment: covid vaccine giant biontech touts promising early data
An mRNA vaccine can potentially boost cell treatments used to fight blood cancer and make them more eff...
April 11, 2022, 12:49 pm
Antibody treatments for covd-19 face challenges in the u.s.
With the emergence of the highly transmissible Omicron variant, the authorized antibody treatments of c...
April 8, 2022, 10:32 am
Astrazeneca has cracked a whole new cancer treatment market, but how much is worth?
Research on AstraZeneca PLC (LSE:AZN) by JP Morgan underlined the scale of the opportunity on offer for the micro-cap life sciences companies developi...
April 7, 2022, 8:38 am
Betterlife says betr-001 demonstrates strong anti-depressant activity in preclinical models of depression
BetterLife Pharma Inc (CSE:BETR, OTCQB:BETRF), a biotech company focused on the development and commercialization of cutting-edge ...
April 6, 2022, 1:03 pm
Baxter's (bax) st set receives fda nod, to boost patient outcome
Baxter's (BAX) ST Set is expected to improve treatments in an acute care environment....
April 6, 2022, 12:48 pm
Ocuphire pharma to present at wet amd & dme drug development summit in boston, ma
FARMINGTON HILLS, Mich., April 06, 2022 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical compan...
April 6, 2022, 8:00 am
Aslan pharmaceuticals to present at the annual needham virtual healthcare conference 2022
MENLO PARK, Calif. and SINGAPORE, April 06, 2022 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN), a clinical-stage, immunology-focused biophar...
April 6, 2022, 7:00 am
Mgc pharmaceuticals agrees european distribution deal for cannabinoid treatments
MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) has signed an exclusive distribution for the UK and certain EU countries for its proprietary can...
April 5, 2022, 3:00 am
Mydecine ends fy2021 with c$1.5m in cash to help propel mental health treatment initiatives in 2022
Mydecine Innovations Group Inc (OTC:MYCOF, NEO:MYCO) ended 2021 with C$1.5 million in cash and decribed the just-ended financial year as one in which...
April 1, 2022, 9:26 am
Phathom pharmaceuticals to present at the 21st annual needham virtual healthcare conference
FLORHAM PARK, N.J., April 01, 2022 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company f...
April 1, 2022, 8:01 am
Vyant bio enters collaboration with organotherapeutics to find treatments for parkinson's disease
Vyant Bio (NASDAQ:VYNT) Inc said it has entered into a collaboration agreement with OrganoTherapeutics to accelerate the discovery of drugs to treat P...
March 30, 2022, 7:20 am
Tyme technologies shares jump premarket on news board to explore strategic options
Tyme Technologies Inc. TYME, -5.56% , a biotech developing cancer metabolism-based treatments, said Tue...
March 29, 2022, 8:01 am
Iovance biotherapeutics: an unproven biopharmaceutical company with significant upside
Iovance Biotherapeutics focuses on developing treatments for cancers, a market with minimal supply and ...
March 25, 2022, 3:46 am